Evidence map›Paper›PMID 30251223›Full record

ArticleIntensive care medicine experimental2018

Bench Validation of a Compact Low-Flow CO

Alexandra G May, R Garrett Jeffries, Brian J Frankowski, Greg W Burgreen, William J Federspiel

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Intensive care medicine experimental, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Improvement of a Mathematical Model to Predict COBioengineering (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Suitable COBioengineering (Basel, Switzerland) · 2021
    Article
  5. A mock circulation loop to test extracorporeal COIntensive care medicine experimental · 2020
    Article
  6. In vivo testing of the low-flow COIntensive care medicine experimental · 2020
    Article
  7. In vitro characterization of PrismaLung+: a novel ECCOIntensive care medicine experimental · 2020
    Article
  8. Effect of Hematocrit on the CO2 Removal Rate of Artificial Lungs.ASAIO journal (American Society for Artificial Internal Organs : 1992)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Alexandra G MayDepartment of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, USA.
R Garrett JeffriesMcGowan Institute for Regenerative Medicine, University of Pittsburgh, 3025 East Carson Street, Suite 226, Pittsburgh, PA, 15203, USA.
Brian J FrankowskiMcGowan Institute for Regenerative Medicine, University of Pittsburgh, 3025 East Carson Street, Suite 226, Pittsburgh, PA, 15203, USA.
Greg W BurgreenComputational Fluid Dynamics Group, Center for Advanced Vehicular Systems, Mississippi State University, Mississippi State, MS, USA.
William J FederspielDepartment of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, USA. wfedersp@pitt.edu.ORCID http://orcid.org/0000-0002-7068-6779
University of Pittsburgh · USMississippi State University · US

Funding

Cardiovascular Bioengineering Training ProgramT32HL076124 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SANJEEV G SHROFF · 2005 to 2026
$7.0M
Paracorporeal Ambulatory Assist LungR01HL117637 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ANTAKI, JAMES F., DCUNHA, JONATHAN · 2013 to 2017
$3.5M
Ambulatory Assist Lung for ChildrenR01HL135482 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FEDERSPIEL, WILLIAM J., WAGNER, WILLIAM R · 2017 to 2020
$2.9M
National Institutes of Health R01HL117637National Institutes of Health R01HL135482NHLBI NIH HHS R01 HL117637NHLBI NIH HHS R01 HL135482NHLBI NIH HHS T32 HL076124
6 · The paper itself

Abstract

backgroundThere is increasing evidence demonstrating the value of partial extracorporeal CO

methodsA blood analog was used to evaluate the performance of the pump at various impeller rotation rates. In vitro CO

resultsThe integrated pump was able to generate flows up to 700 mL/min against the Hemolung 15.5 Fr dual lumen catheter. The maximum vCO

conclusionsThe LF-PAL met pumping, CO

Indexed as

Acute respiratory distress syndromeArtificial lungCOPDExtracorporeal CO2 removal

Identifiers

PMID30251223
PMCPMC6153260
OpenAlexW2892293853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.